Skip to main content
. 2022 Mar 30;14(4):747. doi: 10.3390/pharmaceutics14040747

Table 5.

In vitro cytotoxicity (IC50 (µM ± SD)) of the free curcumin and its niosomal and thermosensitive gel formulations in the screened malignant cell line.

Cell Line Compound T-24
Free curcumin 48.1 ± 5.1
Curc/GS Niosomes 17.9 ± 0.6
Curc/GS NGel 100.1 ± 6.9
Curc/GS NGelCh 10.3 ± 0.5